Neurodegenerative disease research is entering a transformative era, driven by significant advances in biomarker science, digital health technologies and precision medicine. As the prevalence of disorders such as Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions continues to grow, there is an increasing need for innovative tools that can improve disease detection, optimize clinical trial design and accelerate the development of effective therapies.
This webinar will explore how emerging biomarkers are reshaping the future of clinical research and therapeutic development. From biological and imaging biomarkers to digital and wearable technologies, these advances are providing new opportunities to identify disease earlier, better characterize patient populations, monitor disease progression and evaluate treatment response with greater precision. By generating more objective and actionable data, biomarkers are helping researchers and sponsors make more informed decisions throughout the drug development process.
Through presentations from leading experts in the field, attendees will gain valuable insights into the evolving role of biological, digital and wearable markers in neurodegeneration research. Speakers will discuss how these technologies are supporting more efficient clinical trials, enhancing patient selection strategies, enabling personalized treatment approaches and contributing to the development of next-generation therapies.
The webinar will also highlight real-world applications, operational considerations and emerging trends shaping the future of CNS research. Participants will learn about the opportunities and challenges associated with integrating innovative biomarker strategies into research programs and clinical development initiatives.
This session will provide a practical and forward-looking perspective on the advances transforming neurodegenerative disease research. As the field moves toward more precise, data-driven, and patient-centered approaches, understanding the role of biomarkers and digital innovation will be essential to advancing the next generation of treatments and improving outcomes for patients worldwide.
Register for this webinar to learn how biomarker strategies in neurodegeneration can improve disease detection, clinical trial design and treatment monitoring.
Speakers
Anne Marie Nagy, EVP Europe and ROW Operations, Clinilabs
Message Presenter
Robin Wolz, PhD, Chief Scientific Officer, IXICO
Message Presenter
Brian Murphy, PhD, Co-Founder and Chief Scientific Officer, Cumulus Neuroscience Ltd, Cumulus Neuro
Message Presenter
Dr. Bill Byrom, VP, Product Intelligence and Positioning, Principal, eCOA Science, Senior Visiting Professor, Nottingham Trent University, Signant Health
Message PresenterWho Should Attend?
This webinar will appeal to clinicians, researchers and industry professionals involved in neurodegenerative disease research, CNS research, clinical development and drug development.
What You Will Learn
Attendees will:
- Discover how biological, digital, imaging and wearable biomarkers are transforming neurodegenerative disease research and enabling earlier, more precise disease detection
- Learn how biomarker-driven approaches can improve patient selection, optimize clinical trial design and support personalized therapeutic development
- Explore real-world applications of digital health technologies and wearable devices for monitoring disease progression and treatment response
- Gain practical insights into the opportunities, challenges and future trends shaping data-driven CNS drug development and precision medicine
Xtalks Partner
Clinilabs
Clinilabs is a global, full-service clinical research organization (CRO) focused exclusively on central nervous system (CNS) drug, device, and technology development. Drawing on deep, indication-level expertise, a proven process, and the latest technology, we expertly manage Phase 1-3 trials to accelerate treatments for a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS disorders. With 25+ years of global experience, over 800 CNS clinical trial awards completed, and over 30+ marketed products across more than 25 indications, we are the industry’s leading neurotherapeutic clinical trial experts.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account